-transparent.png){kind=logo}
Weanling male and female F 344 rats were given various doses of 1,2-dimethylhydrazine (DMH) or methylazoxymethyl acetate (MAMAc), and were then held for 46-64 weeks in an effort to determine a dose response and establish a dose level which would produce a low level of intestinal neoplasia with a minimal number of tumors in other organs. DMH proved superior to MAM in this respect, although liver lesions were still observed with both compounds at the lowest carcinogenic intestinal dose.
Related Publications
E E McConnell, and
R E Wilson, and
J A Moore, and
J K Haseman
January 1977,
Cancer letters,
E E McConnell, and
R E Wilson, and
J A Moore, and
J K Haseman
August 1978,
Journal of the National Cancer Institute,
E E McConnell, and
R E Wilson, and
J A Moore, and
J K Haseman
September 1989,
Toxicology letters,
E E McConnell, and
R E Wilson, and
J A Moore, and
J K Haseman
November 1989,
Cancer research,
E E McConnell, and
R E Wilson, and
J A Moore, and
J K Haseman
September 1978,
Journal of the National Cancer Institute,
E E McConnell, and
R E Wilson, and
J A Moore, and
J K Haseman
July 1989,
Fundamental and applied toxicology : official journal of the Society of Toxicology,
E E McConnell, and
R E Wilson, and
J A Moore, and
J K Haseman
June 1982,
Gan,
E E McConnell, and
R E Wilson, and
J A Moore, and
J K Haseman
December 1996,
Toxicology,
E E McConnell, and
R E Wilson, and
J A Moore, and
J K Haseman
July 1976,
Chemico-biological interactions,
E E McConnell, and
R E Wilson, and
J A Moore, and
J K Haseman
November 1977,
Cancer research,
